Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Dyne Therapeutics is a US-based biotechnology company dedicated to developing innovative therapies for serious muscle diseases. Through its proprietary FORCE™ platform, Dyne Therapeutics optimizes targeted treatments for patients worldwide suffering from rare genetic disorders.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Dyne Therapeutics is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
Dyne Therapeutics last reported quarterly earnings on 7/29/2026 (Q2 2026). Earnings per share (EPS) came in at -1.08 USD.
Across its last 3 earnings reports, Dyne Therapeutics stock moved by ±3.6% on average the following day. The largest reaction was +4.8% on 05/11/2026; 3 of 3 reactions were positive.
Dyne Therapeutics has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.